CLOSE
MENU
A female doctor explains a procedure to a patient
A female doctor explains a procedure to a patient

Ocular Anaesthetics

Explore Our Product Portfolio:

Please refer to Summary of Product Characteristics before prescribing. Further information about this product can be requested from the Marketing Authorisation Holder or may be found in the Summary of Product Characteristics.

Minims® Proxymetacaine hydrochloride 0.5%
Minims® Proxymetacaine hydrochloride 0.5%

Minims® Proxymetacaine hydrochloride 0.5% w/v

Composition

Proxymetacaine hydrochloride 0.5%, Eye Drops, solution

Indication:

To be used as a topical ocular anaesthetic

Click here for Prescribing Information link-out icon

Minims® Tetracaine hydrochloride 1%
Minims® Tetracaine hydrochloride 1%

Minims® Tetracaine hydrochloride 1% w/v

Composition

Tetracaine hydrochloride 1% w/v, Eye Drops, solution

Indication:

Ocular anaesthetic for topical instillation into the conjunctival sac.

Click here for Prescribing Information link-out icon

Minims® Tetracaine hydrochloride 0.5%
Minims® Tetracaine hydrochloride 0.5%

Minims® Tetracaine hydrochloride 0.5% w/v

Composition

Tetracaine hydrochloride 0.5% w/v, Eye Drops, solution

Indication:

Ocular anaesthetic for topical instillation into the conjunctival sac.

Click here for Prescribing Information link-out icon

Minims® Oxybuprocaine hydrochloride 0.4%
Minims® Oxybuprocaine hydrochloride 0.4%

Minims® Oxybuprocaine hydrochloride 0.4% w/v

Composition

Oxybuprocaine hydrochloride 0.4% w/v

Indication:

As a topical Ocular anaesthetic

Click here for Prescribing Information link-out icon

Reporting side effects:

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bausch + Lomb at: ukmedinformation@bausch.com or call +044 (0) 2087812991

August 2024/MIN.0009.UK.23